SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-000999
Filing Date
2021-02-22
Accepted
2021-02-22 11:19:32
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 859489
2 CERTIFICATION ipix_ex311.htm EX-31.1 10172
3 CERTIFICATION ipix_ex321.htm EX-32.1 4050
  Complete submission text file 0001477932-21-000999.txt   4682532

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ipix-20201231.xml EX-101.INS 725069
5 XBRL TAXONOMY EXTENSION SCHEMA ipix-20201231.xsd EX-101.SCH 83143
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20201231_lab.xml EX-101.LAB 389976
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20201231_cal.xml EX-101.CAL 49297
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20201231_pre.xml EX-101.PRE 363418
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20201231_def.xml EX-101.DEF 273632
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 21658756
SIC: 2834 Pharmaceutical Preparations